VCA
NVO

Verdence Capital Advisors’s Novo Nordisk NVO Stock Holding History

Verdence Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Buy
+9,675
New +$416K 0.02% 450
2026
Q1 		– Sell
-5,394
Closed -$274K – 725
2025
Q4 		$274K Sell
5,394
-28,409
-84% -$1.45M 0.02% 551
2025
Q3 		$1.79M Sell
33,803
-10,043
-23% -$588K 0.1% 195
2025
Q2 		$3.03M Buy
43,846
+63
+0.1% +$4.29K 0.21% 111
2025
Q1 		$3.04M Sell
43,783
-4,684
-10% -$387K 0.23% 106
2024
Q4 		$4.17M Buy
48,467
+5,490
+13% +$594K 0.34% 69
2024
Q3 		$5.12M Buy
42,977
+6,821
+19% +$910K 0.41% 57
2024
Q2 		$5.16M Sell
36,156
-44
-0.1% -$5.83K 0.46% 51
2024
Q1 		$4.65M Sell
36,200
-330
-0.9% -$39.3K 0.42% 57
2023
Q4 		$3.78M Buy
36,530
+3,360
+10% +$332K 0.37% 65
2023
Q3 		$3.02M Buy
33,170
+15,542
+88% +$1.37M 0.33% 78
2023
Q2 		$1.43M Buy
17,628
+9,516
+117% +$777K 0.17% 154
2023
Q1 		$645K Buy
8,112
+1,884
+30% +$134K 0.08% 263
2022
Q4 		$421K Buy
+6,228
New +$365K 0.05% 308

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Verdence Capital Advisors's NVO Position: Q2 2026 in Review

Verdence Capital Advisors opened a new position in Novo Nordisk (NVO) in Q2 2026: 9,675 shares worth $464K. The stake represents 0.02% of the portfolio and ranks #450 among its holdings. This is a return to the name: Verdence Capital Advisors previously reported a position in NVO as recently as Q4 2025.

Verdence Capital Advisors first reported a position in NVO in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.16M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Verdence Capital Advisors held 9,675 shares of Novo Nordisk worth $464K as of Q2 2026.
  • Novo Nordisk was a new Verdence Capital Advisors position in Q2 2026.
  • Novo Nordisk made up 0.02% of Verdence Capital Advisors's portfolio in Q2 2026, its #450 holding.
  • Verdence Capital Advisors first reported a position in Novo Nordisk in Q4 2022 and has held it in 14 quarters since.
  • Verdence Capital Advisors's Novo Nordisk position peaked at $5.16M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.